News

The global lipid nanoparticles (LNP) contract development and manufacturing organization (CDMO) market is poised for ...
When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
For decades, the dream of fixing harmful mutations in mitochondrial DNA felt out of reach. Scientists have long known these ...
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
Ticks and the diseases they carry are only becoming more common. But new treatments and vaccines might not be too far off.
University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.
Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...
Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...
Capstan’s core technology comprises targeted lipid nanoparticles (tLNPs) to enable engineering or ablation of pathogenic cells in the body.